Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vestipitant + Ondansetron for PONV Prevention
NCT00600990Phase 2Completed
- Sponsor
- GSK
- Start
- Dec 2004
- Primary completion
- Jul 2006
- Modality
- Orthosteric Ligands
- Countries
- 12
01
Overview
A Phase 2 trial of vestipitant in postoperative nausea and vomiting (PONV), sponsored by GSK. Started Dec 2004; status: completed.
02
Drugs
vestipitant
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT00600990.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00600990.